# Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury

> **NCT04051957** · PHASE2 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 9 (actual)

## Conditions studied

- Kidney Injury
- Proteinuria
- Hypertension

## Interventions

- **DRUG:** Isosorbide Mononitrate
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04051957
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-26
- **Primary completion:** 2021-02-12
- **Final completion:** 2021-02-12
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Delays due to COVID and loss of research coordinator.
- **Last updated:** 2022-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04051957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04051957, "Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04051957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*